Selective killing of cancer cells by silica nanoparticles due to increased nanoparticle internalization and cellular sensitivity to oxidative stress
Source abstract
Abstract
Silica Nanoparticles (SNPs) have been found to exhibit higher cytotoxicity to various cancer cells than to normal cells, while the underlying mechanisms are not fully understood. Here, SNPs triggered much higher cytotoxicity and apoptosis rate in human hepatoma HepG2 cells than in their normal counterparts L-02 cells; we thus selected these two cell lines as the cell model to investigate the mechanisms involved in the SNP-induced selective toxicity to cancer cells. Although uptake pathways and cellular trafficking of SNPs in HepG2 and L-02 cells were similar, more SNPs were taken up and accumulated in the mitochondria of cancer cells. After the removal of free SNPs from the culture medium, nanoparticles were excreted from HepG2 cells more effectively in the first 24 h, but 72 h later more SNPs still remained in cancer cells, leading to the continuous drop in cell viability of HepG2 cells. SNPs triggered a higher ROS generation, along with a lower intracellular GSH content and CAT activity in HepG2 cells than in L-02 cells. This could be due to the fact that HepG2 cells showed a much lower tolerance to H2O2-induced oxidative stress and cell death. Thus, the selective cytotoxicity of SNPs towards cancer cells could probably be explained by the higher particle uptake efficiency and cell sensitivity to oxidative stress as observed in HepG2 cells.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Arsenic contamination and mitigation · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Kirtane AR, Verma M, Karandikar P (2021) Nanotechnology approaches for global infectious diseases. Nat Nanotechnol 16(4):369–38410.1038/s41565-021-00866-8 ↗
2. Salamanca-Buentello F, Daar AS (2021) Nanotechnology, equity and global health. Nat Nanotechnol 16(4):358–36110.1038/s41565-021-00899-z ↗
3. Jeelani PGH, Mulay P, Venkat R, Ramalingam C (2020) Multifaceted application of silica nanoparticles. A review Silicon 12(6):1337–135410.1007/s12633-019-00229-y ↗
4. Rastogi A, Tripathi DK, Yadav S, Chauhan DK, Zivcak M, Ghorbanpour M (2019) Application of silicon nanoparticles in agriculture. 3 Biotech 9(3):1–1110.1007/s13205-019-1626-7 ↗
5. Yang Y, Zhang M, Song H, Yu C (2020) Silica-based nanoparticles for biomedical applications: from nanocarriers to biomodulators. Acc Chem Res 53(8):1545–155610.1021/acs.accounts.0c00280 ↗
6. Tokgun O, Demiray A, Kaya B, Karagur E, Demir E, Burunkaya E, Akca H (2015) Silica nanoparticles can induce apoptosis via dead receptor and caspase 8 pathway on A549 cells. Adv Food Sci 37:65–70
7. Krętowski R, Kusaczuk M, Naumowicz M, Kotyńska J, Szynaka B, Cechowska-Pasko M (2017) The effects of silica nanoparticles on apoptosis and autophagy of glioblastoma cell lines. Nanomaterials 7(8):23010.3390/nano7080230 ↗
8. Niu Y, Tang E, Zhang Q (2019) Cytotoxic effect of silica nanoparticles against hepatocellular carcinoma cells through necroptosis induction. Toxicol Res 8(6):1042–104910.1039/c9tx00240e ↗
9. Yu Y, Duan J, Yu Y, Li Y, Liu X, Zhou X, Ho K, Tian L, Sun Z et al (2014) Silica nanoparticles induce autophagy and autophagic cell death in HepG2 cells triggered by reactive oxygen species. J Hazard Mater 270:176–18610.1016/j.jhazmat.2014.01.028 ↗
10. Lu X, Qian J, Zhou H, Gan Q, Tang W, Lu J, Yuan Y, Liu C (2011) In vitro cytotoxicity and induction of apoptosis by silica nanoparticles in human HepG2 hepatoma cells. Int J Nanomedicine 6:1889–1901
11. Beddoes CM, Case CP, Briscoe WH (2015) Understanding nanoparticle cellular entry: a physicochemical perspective. Adv Colloid Interface Sci 218:48–6810.1016/j.cis.2015.01.007 ↗
12. Malugin A, Herd H, Ghandehari H (2011) Differential toxicity of amorphous silica nanoparticles toward phagocytic and epithelial cells. J Nanopart Res 13(10):5381–539610.1007/s11051-011-0524-7 ↗
13. Blechinger J, Bauer AT, Torrano AA, Gorzelanny C, Brauchle C, Schneider SW et al (2013) Uptake kinetics and nanotoxicity of silica nanoparticles are cell type dependent. Small 9(23):3970–398010.1002/smll.201301004 ↗
14. Perez-Garnes M, Gutierrez-Salmeron M, Morales V, Chocarro-Calvo A, Sanz R, Garcia-Jimenez C, Garcia-Munoz RA et al (2020) Engineering hollow mesoporous silica nanoparticles to increase cytotoxicity. Mater Sci Eng C 112:11093510.1016/j.msec.2020.110935 ↗
15. Chu ZQ, Huang YJ, Tao Q, Li Q (2011) Cellular uptake, evolution, and excretion of silica nanoparticles in human cells. Nanoscale 3(8):3291–329910.1039/c1nr10499c ↗
16. Al-Rawi M, Diabate S, Weiss C (2011) Uptake and intracellular localization of submicron and nano-sized SiO2 particles in HeLa cells. Arch Toxicol 85(7):813–82610.1007/s00204-010-0642-5 ↗
17. He Q, Zhang Z, Gao Y, Shi J, Li Y (2009) Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. Small 5(23):2722–272910.1002/smll.200900923 ↗
18. Slowing II, Vivero-Escoto JL, Zhao Y, Kandel K, Peeraphatdit C, Trewyn BG (2011) Exocytosis of mesoporous silica nanoparticles from mammalian cells: from asymmetric cell-to-cell transfer to protein harvesting. Small 7(11):1526–153210.1002/smll.201002077 ↗
19. Yanes RE, Tarn D, Hwang AA, Ferris DP, Sherman SP, Thomas CR (2013) Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition. Small 9(5):697–70410.1002/smll.201201811 ↗
20. Wu Y, Tang W, Wang P, Liu C, Yuan Y, Qian J (2015) Cytotoxicity and cellular uptake of amorphous silica nanoparticles in human cancer cells. Part Part Syst Charact 32(7):779–78710.1002/ppsc.201400167 ↗
21. Lehman SE, Morris AS, Mueller PS, Salem AK, Grassian VH, Larsen SC (2016) Silica nanoparticle-generated ROS as a predictor of cellular toxicity: mechanistic insights and safety by design. Environ Sci Nano 3(1):56–6610.1039/C5EN00179J ↗
22. Wang F, Gao F, Lan M, Yuan H, Huang Y, Liu J (2009) Oxidative stress contributes to silica nanoparticle-induced cytotoxicity in human embryonic kidney cells. Toxicol In Vitro 23(5):808–81510.1016/j.tiv.2009.04.009 ↗
23. Ye Y, Liu J, Xu J, Sun L, Chen M, Lan M (2010) Nano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line. Toxicol In Vitro 24(3):751–75810.1016/j.tiv.2010.01.001 ↗
24. Sosa V, Moline T, Somoza R, Paciucci R, Kondoh H, LLeonart ME (2013) Oxidative stress and cancer: an overview. Ageing Res Rev 12(1):376–39010.1016/j.arr.2012.10.004 ↗
25. Moloney JN, Cotter TG (2018) ROS signalling in the biology of cancer. Semin Cell Dev Biol 80:50–6410.1016/j.semcdb.2017.05.023 ↗
26. Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G (2020) ROS in cancer therapy: the bright side of the moon. Exp Mol Med 52(2):192–20310.1038/s12276-020-0384-2 ↗
27. Reczek CR, Chandel NS (2017) The two faces of reactive oxygen species in cancer. Annu Rev Biochem 1:79–98
28. Cho HD, Lee JH, Moon KD, Park KH, Lee MK, Seo KI (2018) Auriculasin-induced ROS causes prostate cancer cell death via induction of apoptosis. Food Chem Toxicol 111:660–66910.1016/j.fct.2017.12.007 ↗
29. Raza MH, Siraj S, Arshad A, Waheed U, Aldakheel F, Alduraywish S (2017) ROS-modulated therapeutic approaches in cancer treatment. J Cancer Res Clin 143(9):1789–180910.1007/s00432-017-2464-9 ↗
30. Inoue M, Sakamoto K, Suzuki A, Nakai S, Ando A, Shiraki Y (2021) Size and surface modification of silica nanoparticles affect the severity of lung toxicity by modulating endosomal ROS generation in macrophages. Part Fibre Toxicol 18(1):1–2010.1186/s12989-021-00415-0 ↗
31. Lin W, Huang YW, Zhou XD, Ma Y (2006) In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol 217(3):252–25910.1016/j.taap.2006.10.004 ↗
32. Zhu J, Liao L, Zhu L, Zhang P, Guo K, Kong J (2013) Size-dependent cellular uptake efficiency, mechanism, and cytotoxicity of silica nanoparticles toward HeLa cells. Talanta 107:408–41510.1016/j.talanta.2013.01.037 ↗
33. Shahabi S, Treccani L, Dringen R, Rezwan K (2015) Dual fluorophore doped silica nanoparticles for cellular localization studies in multiple stained cells. Acta Biomater 14:208–21610.1016/j.actbio.2014.11.037 ↗
34. Veeranarayanan S, Poulose AC, Mohamed S, Aravind A, Nagaoka Y, Yoshida Y (2012) FITC labeled silica nanoparticles as efficient cell tags: uptake and photostability study in endothelial cells. J Fluoresc 22(2):537–54810.1007/s10895-011-0991-3 ↗
35. Li J, Tian J, Yin H, Peng Y, Liu S, Yao S, Zhang L (2021) Chemical conjugation of FITC to track silica nanoparticles in vivo and in vitro: an emerging method to assess the reproductive toxicity of industrial nanomaterials. Environ Int 152:10649710.1016/j.envint.2021.106497 ↗
36. Saikia J, Yazdimamaghani M, Hadipour Moghaddam SP, Ghandehari H (2016) Differential protein adsorption and cellular uptake of silica nanoparticles based on size and porosity. ACS Appl Mater Interfaces 8(50):34820–3483210.1021/acsami.6b09950 ↗
37. Li L, Xi WS, Su Q, Li Y, Yan GH, Liu Y (2019) Unexpected size effect: the interplay between different-sized nanoparticles in their cellular uptake. Small 15(38):190168710.1002/smll.201901687 ↗
38. Glorani G, Marin R, Canton P, Pinto M, Conti G, Fracasso G (2017) Pegylated silica nanoparticles: cytotoxicity and macrophage uptake. J Nanopart Res 19(8):1–1410.1007/s11051-017-3964-x ↗
39. Hu L, Mao Z, Zhang Y, Gao C (2011) Influences of size of silica particles on the cellular endocytosis, exocytosis and cell activity of HepG2 cells. J Nanosci Lett 1:1–1610.4236/snl.2011.11001 ↗
40. Ivosev V, Sanchez GJ, Stefancikova L, Haidar DA, Gonzalez Vargas CR, Yang X (2020) Uptake and excretion dynamics of gold nanoparticles in cancer cells and fibroblasts. Nanotechnology 31(13):13510210.1088/1361-6528/ab5d82 ↗
41. Qi Y, Ma R, Li X, Lv S, Liu X, Abulikemu A (2020) Disturbed mitochondrial quality control involved in hepatocytotoxicity induced by silica nanoparticles. Nanoscale 12(24):13034–1304510.1039/D0NR01893G ↗
42. Menon N, Leong DT (2016) Cytotoxic effects of phosphonate-functionalized mesoporous silica nanoparticles. Acs Appl Mater Inter 8(3):2416–242210.1021/acsami.5b11741 ↗
43. Wang L, Liu Y, Li W, Jiang X, Ji Y, Wu X (2011) Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. Nano Lett 11(2):772–78010.1021/nl103992v ↗
44. Guo CX, Yang M, Jing L, Wang J, Yu Y, Li Y (2016) Amorphous silica nanoparticles trigger vascular endothelial cell injury through apoptosis and autophagy via reactive oxygen species-mediated MAPK/Bcl-2 and PI3K/Akt/mTOR signaling. Int J Nanomedicine 11(2016):5257–527610.2147/IJN.S112030 ↗
45. Kusaczuk M, Kretowski R, Naumowicz M, Stypulkowska A, Cechowska-Pasko M (2018) Silica nanoparticle-induced oxidative stress and mitochondrial damage is followed by activation of intrinsic apoptosis pathway in glioblastoma cells. Int J Nanomedicine 13:2279–229410.2147/IJN.S158393 ↗
46. Ahmad J, Ahamed M, Akhtar MJ, Alrokayan SA, Siddiqui MA, Musarrat J (2012) Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2. Toxicol Appl Pharmacol 259(2):160–16810.1016/j.taap.2011.12.020 ↗
47. Sabharwal SS, Schumacker PT (2014) Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel? Nat Rev Cancer 14(11):709–72110.1038/nrc3803 ↗
48. Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12(12):931–94710.1038/nrd4002 ↗
49. Wang J, Yi J (2008) Cancer cell killing via ROS To increase or decrease, that is the question. Cancer Biol Ther 7(12):1875–188410.4161/cbt.7.12.7067 ↗
50. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H (2006) Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 10(3):241–25210.1016/j.ccr.2006.08.009 ↗
51. Khan MI, Mohammad A, Patil G, Naqvi SA, Chauhan LK, Ahmad I (2012) Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. Biomaterials 33(5):1477–148810.1016/j.biomaterials.2011.10.080 ↗
52. Kong N, Ji X, Wang J, Sun X, Chen G, Fan T (2020) ROS-mediated selective killing effect of black phosphorus: mechanistic understanding and its guidance for safe biomedical applications. Nano Lett 20(5):3943–395510.1021/acs.nanolett.0c01098 ↗
53. Berg JM, Romoser AA, Figueroa DE, Spencer West C, Sayes CM (2013) Comparative cytological responses of lung epithelial and pleural mesothelial cells following in vitro exposure to nanoscale SiO2. Toxicol In Vitro 27(1):24–3310.1016/j.tiv.2012.09.002 ↗
54. Kung ML, Hsieh SL, Wu CC, Chu TH, Lin YC, Yeh BW (2015) Enhanced reactive oxygen species overexpression by CuO nanoparticles in poorly differentiated hepatocellular carcinoma cells. Nanoscale 7(5):1820–182910.1039/C4NR05843G ↗
55. Kim IY, Joachim E, Choi H, Kim K (2015) Toxicity of silica nanoparticles depends on size, dose, and cell type. Nanomedicine 11(6):1407–141610.1016/j.nano.2015.03.004 ↗